C.S. Mott Children's Hospital — Ann Arbor, Michigan

Public research footprint of C.S. Mott Children's Hospital, compiled from the ClinicalTrials.gov public registry.

149

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Neuroblastoma · High Grade Glioma · Glioblastoma Multiforme · Diffuse Midline Glioma, H3 K27M-Mutant

Recently updated registry entries

NCT05265273 — A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized… (Recruiting)
NCT06450041 — NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb)… (Recruiting)
NCT05999994 — A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at C.S. Mott Children's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.